Focus Partners Wealth

Position in ZTS — Zoetis Inc.

CIK 1542153 ST LOUIS, MO

Position in ZTS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$16,287,446

-$319,913 QoQ

Shares Held

137,784

+4.4% QoQ

Ownership

0.033%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 59.42253195303915.ToString("F0")% Shared 0.ToString("F0")% None 40.577468046960846.ToString("F0")%

Healthcare · as of Mar 31, 2026

Focus Partners Wealth holds $54,434,760 across 17 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (29.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc. This page	137,784	$16,287,446
2	NBIX	Neurocrine Biosciences Inc	80,335	$10,583,332
3	TAK	Takeda Pharmaceutical Co Ltd	482,387	$8,933,807
4	LNTH	Lantheus Holdings, Inc.	72,517	$5,500,414
5	UTHR	UNITED THERAPEUTICS Corp	5,854	$3,471,304
6	ALKS	Alkermes plc.	77,052	$2,724,558
7	HLN	Haleon plc	195,548	$1,957,435
8	VTRS	Viatris Inc	132,034	$1,783,779

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$16,287,446	137,784	+4.4%	Shares	Sole	2026-05-15
2025-12-31	$16,607,359	131,993	+48.2%	Shares	Sole	2026-02-13
2025-09-30	$13,036,234	89,094	-2.7%	Shares	Sole	2025-11-14
2025-06-30	$14,279,093	91,562	-15.7%	Shares	Sole	2025-08-14
2025-03-31	$17,884,283	108,620	-2.7%	Shares	Sole	2025-05-20
2024-12-31	$18,182,336	111,596	-68.0%	Shares	Sole	2025-05-29
2024-09-30	$68,236,660	349,251	+540.3%	Shares	Sole	2024-11-14
2024-06-30	$9,455,227	54,541	+28.1%	Shares	Sole	2024-08-15
2024-03-31	$7,204,623	42,578	+270.6%	Shares	Sole	2024-05-16
2023-12-31	$2,267,781	11,490	—	Shares	Sole	2024-02-15
No filing history on record for this holder in this stock.